Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Piper vs Potere Health MD

Piper
Graded #34

Higher grade

vs+9.400000000000006
Potere Health MD
Graded #77

Lower grade

The verdict

Piper takes it — 81.9/100 to 72.5/100.

Piper grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mid-value both-molecule pricing ($135/$199), nationwide, though not verified.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePiper +1
86
85
Dose & formulationPiper +16
80
64
Clinical oversightPotere Health MD +8
79
87
Labs & monitoringPiper +24
78
54
FulfillmentPiper +19
86
67
Contract termsPiper +21
82
61
Piper · left barPotere Health MD · right bar

The numbers

MetricPiperPotere Health MD
WeighScore81.9/10072.5/100
GradeB−C
Scorecard rank#34#77
Semaglutide$135/mo$80/mo (starting dose, compounded)
Tirzepatide$199/mo$135/mo (starting dose, compounded)
CoverageAll 50 states1 state
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Piper

Graded #34 · B−

Strengths

  • $135 sema / $199 tirz
  • All 50 states
  • Both molecules

Where it loses points

  • Not LegitScript-verified
  • Injection-only
  • Monitoring detail limited
Potere Health MD

Graded #77 · C

Strengths

  • Low starting pricing (about $80-$135/month) with no subscription lock-in
  • Physician-led by a named MD, not automated messaging
  • Third-party COA and LegitScript-certified pharmacy
  • Both telehealth and in-person Utah visits with fast scheduling

Where it loses points

  • Available in Utah only — a St George clinic offering telehealth within the state, not a national service
  • The per-vial price is fixed, so the monthly cost rises steeply with the dose: the provider's own table runs about $20/mo at 0.25 mg, $80/mo at 1.0 mg and about $199/mo at 2.5 mg
  • Medication is bought per vial up front rather than on a subscription, so there is no monthly rate to compare directly against a subscription programme
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard